At a glance
ClinicalIndex Comparison RecordStandardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
SCENT Trial: Nasal Theophylline Irrigation for Treatment of Post-Viral Olfactory Dysfunction
In Brief
A Phase 2 clinical trial evaluating Theophylline and Saline Nasal for Olfactory Disorder and 4 related conditions. Completed, enrolled 27 participants across 1 site.
Detailed Summary
This study evaluates the efficacy and safety of nasal theophylline irrigation in treating smell loss related to a viral respiratory infection. Half the participants will undergo nasal theophylline irrigation treatment while the other half will undergo placebo nasal irrigation with saline alone. All participants will have their sense of smell tested before and after 6 weeks of treatment. All participants will also be regularly asked about any potential side effects related to treatment. In addition, the first 10 participants will have their blood drawn to measure their theophylline level after 1 week of starting treatment to ensure it is not abnormally elevated.
Study Details
Timeline
Interventions
Theophylline delivered via high-volume, low-pressure nasal saline irrigation
Lactose delivered via high-volume, low-pressure nasal saline irrigation